Clover Health Investments Corp (NASDAQ: CLOV) on Monday, plunged -1.44% from the previous trading day, before settling in for the closing price of $3.48. Within the past 52 weeks, CLOV’s price has moved between $0.61 and $4.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 52.25%. The company achieved an average annual earnings per share of 73.31%. With a float of $376.94 million, this company’s outstanding shares have now reached $394.44 million.
Let’s determine the extent of company efficiency that accounts for 552 employees. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Breakdown of a Key Holders of the stock
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of Clover Health Investments Corp is 24.78%, while institutional ownership is 16.38%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 73.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Clover Health Investments Corp (CLOV) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Looking closely at Clover Health Investments Corp (NASDAQ: CLOV), its last 5-days average volume was 4.57 million, which is a drop from its year-to-date volume of 7.94 million. As of the previous 9 days, the stock’s Stochastic %D was 76.87%. Additionally, its Average True Range was 0.20.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 60.74%, which indicates a significant decrease from 77.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.07% in the past 14 days, which was lower than the 94.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.63, while its 200-day Moving Average is $1.96. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $3.50. Second resistance stands at $3.56. The third major resistance level sits at $3.65. If the price goes on to break the first support level at $3.34, it is likely to go to the next support level at $3.25. Now, if the price goes above the second support level, the third support stands at $3.19.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
Market capitalization of the company is 1.75 billion based on 501,109K outstanding shares. Right now, sales total 2,034 M and income totals -213,360 K. The company made 330,990 K in profit during its latest quarter, and -9,160 K in sales during its previous quarter.
